期刊文献+

膨体聚四氟乙烯人工二尖瓣的体外加速疲劳实验 被引量:5

In vitro accelerative fatigue test of expanded polytetrafluoroethylene mitral valve prothesis
下载PDF
导出
摘要 目的:测试膨体聚四氟乙烯人工二尖瓣的体外耐久性。方法:实验于2004-11/2005-06在湖南心脏研究所完成。符合GB12279-90标准。疲劳实验前后进行体外脉动流流体力学实验。实验在20℃恒温条件下进行,采用生理盐水作为实验液体。以TH-2200型瓣膜体外加速疲劳寿命实验台对6个膨体聚四氟乙烯人工二尖瓣进行体外加速疲劳实验,总计4亿次,实验中每2500万次停机检查1次,每5000万次测量腱索长度。实验结束时观察瓣膜的大体情况。以TH-1200型人工心脏瓣膜体外脉动流试验台测试瓣膜于疲劳实验前后的流体力学参数,并进行对比,以测试膨体聚四氟乙烯人工二尖瓣的耐久性。结果:①瓣膜大体观察:6个膨体聚四氟乙烯人工二尖瓣在每个周期的循环中均能够完全开放与闭合,每个膨体聚四氟乙烯人工二尖瓣的腱索均处于张紧状态,瓣膜大小瓣间对合严密,无肉眼可见的缝隙。②腱索长度变化:腱索长度随时间(实验次数)的增加而增加,但增加速度逐渐减慢,0.5亿次时平均增加(0.795±0.037)mm,1亿次时增加(0.587±0.044)mm,以后增加缓慢,不超过(0.168±0.021)mm。由实验开始到结束时各腱索总计增加长度均值为1.86mm。总体上随时间变化腱索增长差异有显著性意义(F=5025.909,P=0.000)。腱索长度增加各腱索间差异无显著性意义(F=2.119,P=0.067)。③平均跨瓣压差:疲劳实验后平均跨瓣压差略高于实验前,差异无显著性意义[分别为(4.540±1.846),(4.498±1.430)mmHg,F=0.013,P=0.912]。④瓣膜有效开口面积:疲劳实验后瓣膜有效开口面积略高于实验前,差异无显著性意义[分别为(2.633±1.077),(2.474±1.074)cm2,F=0.651,P=0.427]。⑤瓣膜反流量:疲劳实验后瓣膜反流量低于实验前,差异有显著性意义[分别为(1.291±1.028),(2.128±1.250)mL,F=8.606,P=0.007]。⑥瓣膜反流率:疲劳实验后瓣膜反流率低于实验前,差异有显著性意义[分别为(3.491±2.998)%,(5.147±1.736)%,F=5.849,P=0.023]。结论:膨体聚四氟乙烯人工二尖瓣具有良好的体外耐久性及流体力学特性。 AIM: To study the durability of expanded polytetrafluoroethylene mitral valve prothesis (ePTFEMVP). METHODS : The experiment was conducted in the laboratory of Hunan Angiocardiopathy Institute from November 2004 to June 2005, and the experimental processes wore consistent with the specifications of GB12279-90. In vitro pulsing hydromechanical experiment was performed before and after fatigue experiment. The experiment was carried on at 20℃ with normal sodium as the work fluid. Six ePTFEMVPs wore tested for 400 million times with accelerative fatigue with TH-2200 artificial heart valve exosomatic accelerative fatigue instrument. The valves wore checked every 25 million times and the length of chorda tendineaes was checked every 50 million times during the test. The general condition of mitral valve was observed when the experiment was completed. Hydromechanical parameters before and after the accelerative fatigue test wore tested with TH-1200 artificial heart valve exosomatic pulsatile stream instrument and compared to estimate the durability of the ePTFEMVP. RESULTS : ①General observation results: All six ePTFEMVPs could open and close completely in every cycle. All chorda tendineaes wore tensive and the big and small cusps wore jointed tightly without macroscopic crevices. ② Length changes of chorda tendineaes: The length was increased with time (experimental times), but the increase rate gradually slowed down. At 50 million times the mean length increase was (0.795±0.037) mm and at 100 million times it was (0.587±0.044) mm, then it gradually slowed down, and did not excess (0.168±0.021) mm. From the beginning to the end of the accelerated fatigue test the mean total length increase was 1.86 mm. Generally the differences of the length increase with time wore extremely statistically significant (F =5 025.909, P =0.000). The length increase differences among chorda tendineaes wore not statistically significant (F =2.119, P =0.067). ③Mean pressure difference: It slightly increased compared with that before the test, but the difference was not statistically significant [(4.540± 1.846), (4.498±1.430) mm Hg, F =0.013,. P =0.912]. ④Effective orifice area: It slightly increased compared with that before the fatigue test, but the difference was not statistically significant [(2.633±1.077), (2.474±1.074) cm^2, F =0.651, P =0.427]. ⑤Regurgitation volume: The regurgitation volume was diminished after the accelerative fatigue test and the differencec wore statistically significant [(1.291±1.028), (2.128±1.250) mL, F=8.606, P =0.007]. ⑥Regurgitation rate: It was lower than that before the accelerative fatigue test and the differencec wore statistically significant [(3.491±2.998)%, (5.147±1.736)%, F =5.849, P =0.023]. CONCLUSION: The ePTFEMVP has favorable exosomatic durability and hydromechanical characteristics.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2007年第1期58-62,共5页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 广东省科技计划项目(2002B11703)~~
  • 相关文献

参考文献19

  • 1徐秀林,张京航,梁伟,邹任玲,徐根林.人工心脏瓣膜质量及安全性评价[J].中国医疗器械杂志,2004,28(5):360-362. 被引量:9
  • 2Teebken OE,Wilhelmi M,Haverich A.Tissue engineering for heart valves and vascular grafts.Chirurg 2005;76(5):453-466
  • 3Kajiwara H,Hamada T,Ichikawa Y,et al.Experience with expanded polytetrafluoroethylene (ePTFE Gore-Tex) surgical membrane for coronary artery grafting:does ePTFE surgical membrane predispose to postoperative mediastinitis?Artif Organs 2004;28(9):840-845
  • 4Huilgol RL,Young J,Lemech L,et al,Durability of autogenous vein and polytetrafluoroethylene bypass grafts to the carotid arteries.ANZ J Surg 2006;76(10):878-881
  • 5Kasegawa H,Shimokawa T,Shibazaki I,et al.Mitral valve repair for anterior leaflet prolapse with expanded polytetrafluoroethylene sutures.Ann Thorac Surg 2006;81(5):1625-1631
  • 6Tomita Y,Yasul H,Iwai T,et al.Extensive use of polytetrafluoroethylene artificial grafts for prolapse of posterior mitral leaflet.Ann Thorac Surg2004;78(3):815-819
  • 7Isaka M,Nishibe T,Okuda Y,et al.Experimental stucly on stability of a high-porosity expanded polytetrafluoroethylene graft in dogs.Ann Thorac Cardiovasc Surg 2006;12(1):37-41
  • 8祁国奇,朱晓东,胡盛寿,吴清玉,周玉燕.人工心脏瓣膜置换手术后的远期随访[J].中华胸心血管外科杂志,2003,19(4):193-197. 被引量:30
  • 9Doenst T,Borger MA,David TE.Long-term results of bioprosthetic mitral valve replacement:the pericardial perspective.J Cardiovasc Surg (Torino)2004;45(5):449-454
  • 10Butterfield M,Wheatley DJ,Williams DF,et al.A new design for polyurethane heart valves.J Heart Valve Dis 2001 ;10(1):105-110

二级参考文献38

  • 1刘侠,乐以伦.碱性磷酸酶与钙化[J].中国生物医学工程学报,1997,16(1):70-88. 被引量:40
  • 2[1]Corden J, David T, Fisher J. The influence of open leaflet geometry on the haemodynamic flow characteristics of polyurethane trileaflet artifricial heart valves[J]. Proc Inst Mech Eng [H], 1996, 210(4):273-87.
  • 3[2]Butterfield M, Wheatley DJ, Williams DF, et al. A new design for polyurethane heart valves[ J ]. J Heart Valve Dis, 2001, 10(1):105-1 0.
  • 4[3]Wheatley DJ, Raco L, Bernacca GM, et al. Polyurethane: material for the next generation of heart valve prostheses [ J ]? Eur J Cardiothorac Surg, 2000, 17(4): 440-8.
  • 5[4]Stevensn DM, Yoganathan AP, Franch RH. The Bjork-Shiley heart value prosthesis flow characteristics of the new 70° model [J].Scand J Thorac Cardiovasc Surg, 1982, 16(1): 1.
  • 6[5]Scotten LN, Walker DK, Brownlee RT. The Bjork-Shiley and Lonescu-Shiley heart valve prosthesis in vitro comparison of their hydrodynamic performance in the mitral position[J]. Scand J Thorac Cardiovasc Surg, 1983, 17(2): 201.
  • 7Edmunds LH, Clark RE, Cohn LH, etal. Guiddines far mmbidity and mortality after cardiac valvular operation. J Thorac Cardiovaac Surg, 1996,112:708-711.
  • 8Jamieson WR, Edwards FH, Bern JW, et al. Pisk straatificatian for cardiac valve replacement. National Cardiac Surgery Database Committee of The Society of Thoracic Surgeons. Ann Thorac Surg, 1999, 67:943-951.
  • 9Flameng WJ, Herijgers P, Szcsi J, et al. Determinants of early and late resuits of combined valve operations and coronary eatery bypess grafting. Ann Thorac Surg, 1996,61:621 - 628.
  • 10Karp RB, Mills N, Edmunds LH Jr.Coronary artery bypase garfting in the presence of valvular disease. Circulation, 1989,79(6 Pt 2):1182-184.

共引文献51

同被引文献70

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部